Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.
Clinical trial NCT00069836 · COMPLETED
Trial details
- NCT number
- NCT00069836
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2004-11-01
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.